Industry News
Medical Device Industry News
Reprise Biomedical’s Miro3D® Wound Matrix Granted Level II HCPCS Code by CMS
Reprise Biomedical, Inc., a leading innovator in medical biotechnology for wound care, is pleased to announce that the Centers for Medicare and Medicaid Services (CMS) has assigned a Level II Healthcare Common Procedure Coding System
Semaglutide Weight Loss: Dangerous Side Effects, Cost, Results and Alternative
(Semaglutide Weight Loss and a Safer Alternative) If you’ve been keeping up with the latest advancements in diabetes treatment, you may have come across the term “Semaglutide.” But what exactly is Semaglutide, and why is
Medtech in a Minute: A Shocking CEO Move, and More
Catch up on the latest medtech news – in one minute or less.
Why Vape Without Nicotine?
Vaping’s not just trending. It’s exploding. From clouds of smoke in alleys to fragrant plumes in hip cafes, vaping is everywhere. But there’s a twist. People are starting to explore vaping without the addictive nicotine.
Turning Goober Moments into Priceless Wisdom
This week in Pedersen's POV, our senior editor discusses the value of building a forward-thinking corporate culture in medtech.
UV-Free Air Decontamination: Interview with Sorel Rothschild, VP at Quantum Innovations
LumaFlo, a medtech company based in Israel, has developed a decontamination technology that does not require UV light, something that can be dangerous for people nearby. The COVID-19 pandemic highlighted the need for safe and
mRNA Immunotherapy Targets Cancer
Researchers at the Mount Sinai Hospital have developed an mRNA-based treatment for cancer. The approach combines the delivery of mRNA therapy in lipid nanoparticles and also involves co-delivering dendritic cells that have also been primed
Health Is A Personal Journey, But It Needn’t Be Faced Alone
You have to agree, that nothing in this life is more important than health and wellness. Furthermore, only you can take responsibility by actively prioritizing your health. However, you do not need to walk the
Gene Therapy Targets Chronic Pain
Scientists at New York University have developed a gene therapy for chronic pain. The technology works by targeting the NaV1.7 sodium ion channel present on neurons, which is an important component of the pain response.
AusperBio Announces FDA Clearance of IND Application of AHB-137 in Chronic Hepatitis B Treatment
"The FDA's clearance of our IND application to initiate clinical evaluation of AHB-137 in CHB patients in the United States brings us one step closer to introducing a potential functional cure for people living with HBV." said
Janssen Submits Supplemental Biologics License Application to the U.S. Food and Drug Administration Seeking Approval of RYBREVANT® (amivantamab-vmjw) in Combination with Chemotherapy for the First-line Treatment of Patients with Locally Advanced or Metastatic EGFR Exon 20 Insertion Mutation-Positive Non-Small Cell Lung Cancer
"PAPILLON is the first randomized Phase 3 study in patients with NSCLC with EGFR exon 20 insertion mutations to show clinically meaningful results. This creates an opportunity to make a significant improvement to the standard
First Participant Treated at the Highest Dose Level in Clarity’s Theranostic Prostate Cancer Trial
Clarity's Executive Chairperson, Dr Alan Taylor, commented, "Results from cohort 2 are incredibly exciting and we look forward to seeing data from the increased dosing of 12GBq as well as discover the potential positive effects of
First Cancer Patient Treated Using RefleXion’s Scintix Radiotherapy
The RefleXion X1 PET-CT machine with Scintix therapy is a hybrid platform that uses both biologic technology for tumors in motion and anatomic capabilities through X1’s fan-beam kVCT.
Viz.ai Signs License Agreement with UCSF to Commercialize Three Cardiac Artificial Intelligence Algorithms
Exclusive agreement for AI algorithms to accelerate earlier detection of cardiac amyloidosis and pulmonary hypertension notes Viz.ai.
GE HealthCare Introduces Vscan Air SL, a Wireless Handheld Ultrasound Device for Rapid Assessments of Cardiac and Vascular Patients
The latest addition to the Vscan product suite, Vscan Air SL features GE HealthCare’s proprietary SignalMax and XDclear technology that provide high levels of penetration, resolution, and sensitivity in imaging performance with an industry-leading single
Thryv Therapeutics Announces Positive Results from the WAVE 1 Proof of Concept Study in Long QT Syndrome. LQT-1213 Rapidly and Meaningfully Reduces QT Interval in Individuals with Prolonged QT induced by Dofetilide
"Over the past few years, our research has continued to validate the pathogenic role of SGK-1 in rare arrhythmias. We now have the first in human evidence of the benefits of targeting this activated kinase
Global Breast Lesion Localization Research Report 2023-2028: Advancements in Imaging Technology Fuel Detection of Clinically Occult Breast Lesions, Propelling Localization Market
The breast lesion localization market is expected to reach USD 387.4 million by 2028 from USD 278.1 million in 2023, at a CAGR of 6.9%.
GE Healthcare Launch Vscan Air SL Handheld Ultrasound Imaging System
The device is the latest in the company’s Vscan Air product line, which brought the CL version to market in 2021.
1 Day Virtual Clinical Evaluation of Medical Devices Training Course: Empower Your Clinical Evidence – Enhancing Skills for MDR-compliant CER Creation
This two-day introductory course will cover all aspects of clinical evaluation in line with the European Medical Device Regulation (MDR) and applicable guidance documents.
The Future of Natural Hormone Replacement Therapy
How we treat hormone imbalances and age-related health problems may undergo a seismic shift as a result of natural hormone replacement therapy (NHRT). As we look to the future of NHRT, a number of trends